+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Enzyme-linked Immunosorbent Assay Testing Market by Test Type (Competitive ELISA, Indirect ELISA, Multiple & Portable ELISA), Application (Cancer, Immunology, Infectious Diseases) - Forecast 2024-2030- Product Image
Global Enzyme-linked Immunosorbent Assay Testing Market by Test Type (Competitive ELISA, Indirect ELISA, Multiple & Portable ELISA), Application (Cancer, Immunology, Infectious Diseases) - Forecast 2024-2030- Product Image
Sale

Global Enzyme-linked Immunosorbent Assay Testing Market by Test Type (Competitive ELISA, Indirect ELISA, Multiple & Portable ELISA), Application (Cancer, Immunology, Infectious Diseases) - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989693
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Enzyme-linked Immunosorbent Assay Testing Market size was estimated at USD 516.39 million in 2023, USD 552.58 million in 2024, and is expected to grow at a CAGR of 7.10% to reach USD 834.77 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Enzyme-linked Immunosorbent Assay Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Enzyme-linked Immunosorbent Assay Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Enzyme-linked Immunosorbent Assay Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam, Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne Corporation, bioMérieux, Inc., Enzo Life Sciences, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Merck KGaA, PerkinElmer, RayBiotech Life Inc., Shenzhen YHLO Biotech Co., Ltd., Thermo Fisher Scientific. Inc., and ZEUS Scientific, Inc. by Sebia.

Market Segmentation & Coverage

This research report categorizes the Enzyme-linked Immunosorbent Assay Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test Type
    • Competitive ELISA
    • Indirect ELISA
    • Multiple & Portable ELISA
    • Sandwich ELISA
  • Application
    • Cancer
    • Immunology
    • Infectious Diseases
    • Inflammation
    • Protein Quantitation
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Enzyme-linked Immunosorbent Assay Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Enzyme-linked Immunosorbent Assay Testing Market?
  3. What are the technology trends and regulatory frameworks in the Enzyme-linked Immunosorbent Assay Testing Market?
  4. What is the market share of the leading vendors in the Enzyme-linked Immunosorbent Assay Testing Market?
  5. Which modes and strategic moves are suitable for entering the Enzyme-linked Immunosorbent Assay Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Enzyme-linked Immunosorbent Assay Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence rate of infectious diseases
5.1.1.2. Need for cost-effective diagnostic tools
5.1.1.3. Government support in increasing infrastructure and treatment initiatives
5.1.2. Restraints
5.1.2.1. Lack of infrastructural faciltities
5.1.3. Opportunities
5.1.3.1. Ongoing developments and launches of the ELISA testing
5.1.3.2. Potential growth for low-cost portable ELISA reader based on image analysis
5.1.4. Challenges
5.1.4.1. Complex assay development workflows
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Enzyme-linked Immunosorbent Assay Testing Market, by Test Type
6.1. Introduction
6.2. Competitive ELISA
6.3. Indirect ELISA
6.4. Multiple & Portable ELISA
6.5. Sandwich ELISA
7. Enzyme-linked Immunosorbent Assay Testing Market, by Application
7.1. Introduction
7.2. Cancer
7.3. Immunology
7.4. Infectious Diseases
7.5. Inflammation
7.6. Protein Quantitation
8. Americas Enzyme-linked Immunosorbent Assay Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Enzyme-linked Immunosorbent Assay Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Enzyme-linked Immunosorbent Assay Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abcam
12.1.2. Agilent Technologies Inc.
12.1.3. Becton, Dickinson and Company
12.1.4. Bio-Rad Laboratories
12.1.5. Bio-Techne Corporation
12.1.6. bioMérieux, Inc.
12.1.7. Enzo Life Sciences, Inc.
12.1.8. Eurofins Scientific SE
12.1.9. F. Hoffmann-La Roche AG
12.1.10. Merck KGaA
12.1.11. PerkinElmer
12.1.12. RayBiotech Life Inc.
12.1.13. Shenzhen YHLO Biotech Co., Ltd.
12.1.14. Thermo Fisher Scientific. Inc.
12.1.15. ZEUS Scientific, Inc. by Sebia
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET RESEARCH PROCESS
FIGURE 2. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET DYNAMICS
FIGURE 7. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 8. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 6. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MULTIPLE & PORTABLE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PROTEIN QUANTITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 24. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 34. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 38. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 40. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 44. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 48. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 50. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 54. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 63. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 65. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 69. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 71. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 75. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 77. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 91. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 93. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 103. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 104. ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • Abcam
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • bioMérieux, Inc.
  • Enzo Life Sciences, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • PerkinElmer
  • RayBiotech Life Inc.
  • Shenzhen YHLO Biotech Co., Ltd.
  • Thermo Fisher Scientific. Inc.
  • ZEUS Scientific, Inc. by Sebia

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 552.58 Million
Forecasted Market Value ( USD ) by 2030 $ 834.77 Million
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis. - Product Image

Global Enzyme-linked Immunosorbent Assay (ELISA) Testing Market (2023-2028) Competitive Analysis, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis.

  • Report
  • 206 Pages
  • Global
From
Research ELISA (Enzyme-Linked Immunosorbent Assay): Global Strategic Business Report - Product Image

Research ELISA (Enzyme-Linked Immunosorbent Assay): Global Strategic Business Report

  • Report
  • 266 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay (ELISA) Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Image

Enzyme-Linked Immunosorbent Assay (ELISA) Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 118 Pages
  • Global
From

About the Enzyme Linked Immunosorbent Assay Test Market

The Enzyme Linked Immunosorbent Assay (ELISA) Test is a type of In Vitro Diagnostics (IVD) test used to detect and measure the presence of antibodies, antigens, and other proteins in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of hormones, toxins, and other substances in the body. The ELISA Test market is a rapidly growing segment of the IVD market. ELISA tests are used in a variety of clinical settings, including hospitals, laboratories, and research facilities. The market is driven by the increasing demand for accurate and reliable diagnostic tests, as well as the development of new technologies and products. Some of the major companies in the ELISA Test market include Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.